Lucy Muniz’s Post

While we have witnessed digital capabilities navigating the pharma through evolving landscape, the question in the realm of CGT remains - how much closer are we to demonstrating value using the universal language of data? Join senior leader from Sumitomo Pharma America, Microvascular Therapeutics, Mustang Bio and Bayer next month, to explore their visions on key trends shaping the future of CGT clinical development: https://bit.ly/3OkH4Ly

Should be an engaging and insightful discussion! Looking forward to hearing from this esteemed panel. #allogeneic #celltherapy #celltherapymanufacturing #atmps #advancedtherapies #cellandgenetherapy

🚨A reminder to register for the upcoming webinar on how to accelerate the development and production of AAV-based therapeutics!  Learn from Regeneron’s Marília Barros and Refeyn’s Matthew Ranaghan about the best analytical strategies to analyze the ratios of empty/full/partial AAV ratios, capsid titers, sample purity and other key quality attributes essential for successful drug development. And of course, how to integrate #MassPhotometry in your workflows for fast, sample-efficient analysis. 🔬📊  Register here 👉 https://lnkd.in/dfMqa7dY

Last week, Argenica Therapeutics lodged our Appendix 4C Quarterly Cashflow Report for the 12-month period ended 30 June 2024. One key highlight from the report was the progress made in our Phase 2 Clinical Trial. Here is an overview of the highlight Access the full report here ➡️ https://bit.ly/4ftygiq #ASX #AGN #investorupdate #stroke #clinicaltrial

#Slack DMs can make it hard to track requests and measure workload impact of your #ITHelpdesk. Hear how Cohere, Xilio Therapeutics and Foqal took back control in 4/17 webinar https://hubs.ly/Q02pyQ0V0

#Slack DMs can make it hard to track requests and measure workload impact of your #ITHelpdesk. Hear how Cohere, Xilio Therapeutics and Foqal took back control 4/17 webinar https://hubs.li/Q02pyTc90

Thoughts on this? >> Context makes a T cell engager deal; Ginkgo Bioworks backers have a new SPAC >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharmaceutical #productmarketing #biotech #healthcare #pharma

What are #digitaltherapeutics bringing that's better or different from traditional treatment approaches?   Dr Pamela Walker and Dr Jessica Shull PhD of Vicore Pharma AB caught up recently to discuss the evolution of the role of digital therapeutics, recent innovations in the space and what impact they may have over the next five years.   Listen to an extract of their conversation below and check out the full episode here: https://lnkd.in/eCk9JwqJ #lifesciences #pharma #pharmainnovation

𝐃𝐲𝐧𝐞 𝐓𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜𝐬 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐏𝐨𝐬𝐢𝐭𝐢𝐯𝐞 𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐃𝐚𝐭𝐚 𝐟𝐫𝐨𝐦 𝐏𝐡𝐚𝐬𝐞 𝟏/𝟐 𝐃𝐄𝐋𝐈𝐕𝐄𝐑 𝐓𝐫𝐢𝐚𝐥 𝐟𝐨𝐫 𝐃𝐘𝐍𝐄-𝟐𝟓𝟏 𝐢𝐧 𝐃𝐮𝐜𝐡𝐞𝐧𝐧𝐞 𝐌𝐮𝐬𝐜𝐮𝐥𝐚𝐫 𝐃𝐲𝐬𝐭𝐫𝐨𝐩𝐡𝐲 (𝐃𝐌𝐃) Dyne Therapeutics (Nasdaq: DYN) Dyne Therapeutics announced new data from its ongoing Phase 1/2 DELIVER trial of DYNE-251 in DMD patients amenable to exon 51 skipping, showing unprecedented dystrophin expression and functional improvement in multiple cohorts. The data highlight DYNE-251's potential to transform the treatment paradigm for Duchenne. Key findings include a mean dystrophin expression of 3.71% at 20 mg/kg, significant functional improvements, and a favorable safety profile. Dyne is now initiating registrational cohorts in the DELIVER trial and will provide an update on the path to registration by year-end 2024. #DMD #MuscularDystrophy #ClinicalTrials #Biotech #Pharma #RareDiseases #GeneTherapy #Biopharma #DrugDevelopment

MEDIcept Minute: Upcoming FDA Webinar - "Regulatory Do’s and Don’ts: Tips from FDA” Exciting news for the industry! Join the FDA and NIH for their latest webinar regarding Regulatory Do’s and Don’ts on September 4, 2024, from 11 AM to 3 PM ET. This event is perfect for early-stage companies and academic spin-offs developing new anticancer therapeutics, devices, and diagnostics. Gain valuable insights into the resources and programs offered by FDA centers (CBER, CDER, CDRH) and learn when to engage with the FDA during preclinical development. Don't miss the Q&A sessions with FDA regulators. Learn more about how you can attend at the link below. https://lnkd.in/eyKhGgC5 For personalized regulatory support, contact MEDIcept Inc. at sales@medicept.com for expert guidance in navigating FDA requirements. #FDA #RegulatoryAffairs #Webinar #MedicalDevices